Infection and Immunity, July 1999, p. 3631-3636, Vol. 67, No. 7
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Correlation of Immunity in Experimental Syphilis
with Serum-Mediated Aggregation of Treponema pallidum Rare
Outer Membrane Proteins
Michael A.
Lewinski,1
James N.
Miller,2
Michael A.
Lovett,2,3 and
David R.
Blanco2,3,*
Department of Microbiology, Immunology, and
Molecular Genetics2 and Department of
Medicine,3 School of Medicine, University of
California at Los Angeles, Los Angeles, California 90095, and
Department of Infectious Diseases, Quest Diagnostics, Inc.,
San Juan Capistrano, California 926901
Received 12 February 1999/Returned for modification 17 March
1999/Accepted 12 April 1999
 |
ABSTRACT |
We have previously shown by freeze-fracture electron microscopy
that serum from infection-immune syphilitic rabbits aggregates the
low-density membrane-spanning Treponema pallidum rare outer membrane proteins (TROMPs). The purpose of this study was to determine if a relationship could be demonstrated between acquired immunity in
experimental rabbit syphilis, serum complement-dependent treponemicidal antibody, and antibody directed against TROMPs as measured by the
aggregation of TROMP particles. Three groups of T. pallidum-infected rabbits were treated curatively with penicillin
at 9 days, 30 days, and 6 months postinfection to generate various
degrees of immunity to challenge reinfection. Sera from rabbits
completely susceptible to localized and disseminated reinfection
possessed a low titer of treponemicidal antibody (
1:1 in killing
50% of a treponemal suspension) and showed a correspondingly low
level of TROMP aggregation (16.5% of the total number of outer
membrane particles counted) similar to normal serum controls (13.4%);
the number of particles within these aggregates never exceeded three. Sera from partially immune rabbits, which were susceptible to local
reinfection but had no evidence of dissemination, showed an increase in
the titer of treponemicidal antibody (1:16) compared to the completely
susceptible group (
1:1). Although no significant increase was
observed in the total number of TROMP particles aggregated (18.9%)
compared to the number in controls (13.4%), approximately 15% of
these aggregates did exhibit a significant increase in the number of
particles per aggregate (4 to 5 particles) compared to controls (
3
particles), indicating a measurable increase in anti-TROMP antibody.
Finally, sera from rabbits completely immune to both local and
disseminated reinfection possessed both high titers of treponemicidal
antibody (1:128) and significant aggregation of TROMP (88.6%);
approximately 50% of these aggregates contained four to six particles.
The results indicate that complete immunity in experimental rabbit
syphilis correlates with antibody that kills T. pallidum
and aggregates TROMPs, suggesting that TROMPs are molecules which
contribute to the development of acquired immunity.
 |
TEXT |
Syphilis, caused by the
noncultivatable spirochete Treponema pallidum subsp.
pallidum, continues to be a significant worldwide venereal
disease. The chronicity of infection in both human and experimental
rabbit syphilis and the slow development of immunity to reinfection
have been well-established (10, 11, 19, 20, 21, 24, 38).
Several lines of evidence support a major role for humoral immunity,
including immune serum passive protection (4, 6, 13, 29, 33,
35-37, 40), inhibition of T. pallidum adherence and
invasion of cultured cell monolayers by immune serum (12, 14,
34), immune serum-mediated phagocytosis of T. pallidum by rabbit peritoneal macrophages (18), and immune serum
complement-dependent treponemicidal antibody (5, 6, 8, 27,
28). It has been demonstrated that a close quantitative
correlation exists between the development of acquired resistance and
the level of treponemicidal antibody (5, 6), suggesting that
killing antibody plays a key role in the acquisition of protective immunity.
One of the more fascinating physical features of T. pallidum
is its strikingly low density of membrane-spanning outer membrane proteins (31, 39) (T. pallidum rare outer
membrane proteins [TROMPs]) which are believed to contribute to the
pathogenic properties of this organism, including its ability to cause
chronic infection and elicit a relatively slow-developing protective
immune response. The aggregation of TROMPs in serum from infected and
immune syphilitic rabbits (7, 9), as viewed by
freeze-fracture electron microscopy, has shown that TROMPs have surface
exposure and therefore represent the most likely surface targets for
complement-dependent treponemicidal antibody.
In order to measure complement-dependent treponemicidal antibody
directed solely against surface targets on T. pallidum, such as TROMPs, we developed a procedure termed the "washed-killing" assay (15). In this system, organisms are preincubated in
heat-inactivated test serum and then washed to remove unbound antibody
prior to the addition of complement. These studies, which utilized
animals with various degrees of resistance to challenge reinfection,
showed a quantitative correlation between the titer of killing antibody and level of acquired immunity, suggesting that killing antibody against surface-exposed molecules is a key mechanism of acquired host resistance.
In the present study, we tested whether a direct relationship between
the status of acquired immunity in experimental rabbit syphilis and
antibody against TROMPs can be demonstrated. In order to most closely
relate serum killing activity and TROMP aggregation to the degree of
protective immunity, sera analyzed in this study were obtained from
postchallenge test animals at the time of lesion appearance in the
control animals. The results show that when syphilitic lesions appeared
in the control animals, complete immunity in the test animals
correlated with the presence of high-titered treponemicidal antibody
and antibody which significantly aggregates TROMPs. These findings
suggest that TROMPs are the primary targets of treponemicidal antibody
and are the molecules responsible for eliciting protective immunity.
Syphilitic infection and curative therapy of rabbits.
Fifty
rabbits were infected intratesticularly with T. pallidum
Nichols and treated with curative doses of penicillin G at various
times postinfection in order to generate different degrees of immunity
to challenge reinfection as previously described (15). Each
animal received 2.5 × 107 T. pallidum
cells per testis. The animals were divided into two groups of 17 rabbits each (groups A and B) and one group of 16 rabbits (group C). At
9 days (group A), 30 days (group B), and 6 months (group C) after
intratesticular infection, each animal was treated with 25,000 U of
aqueous procaine penicillin G/kg of body weight administered
intramuscularly twice daily for 10 days (total of 500,000 U/kg of body
weight). Ten days after therapy was completed, serum from each of the
treated rabbits was shown to be free of penicillin levels capable of
killing T. pallidum, based on the ability of this serum to
support the viability of the organisms for 16 h in vitro. The
efficacy of the treatment was determined 14 days after the completion
of therapy with an infectivity test (23), in which a single
popliteal lymph node and testis from each animal were removed under
anesthesia, suspended in 50% heat-inactivated (56°C for 30 min)
normal rabbit serum (NRS) in phosphate buffered saline, and inoculated
intratesticularly into normal, serologically nonreactive rabbits. The
sensitivity of this assay has been shown to be capable of detecting one
to four virulent T. pallidum cells in a transferred tissue
inoculum (23). Each of the treated animals was found to be
free of infection based on dark-field microscopy-negative aspirates
from the testes and nonreactive venereal disease research laboratory
and T. pallidum immobilization tests (25, 26) on
serum obtained from the recipient rabbits over 6 months.
Immune status of infected and penicillin-treated rabbits.
To
determine susceptibility to reinfection, each penicillin-treated rabbit
and five serologically nonreactive control rabbits were challenged 35 days after therapy with 103 T. pallidum cells at
each of the four intradermal sites as previously described
(15). Each rabbit was examined daily for 90 days for lesion
appearance and development. All lesions in the test and control animals
were observed to appear 11 to 17 days postchallenge. Erythematous,
indurated, well-circumscribed lesions progressing to ulceration were
considered typical, and atypical lesions were characterized as pale,
soft, flat, irregular, and nonprogressive. Aspirates from
representative lesions more than 5 mm in diameter were taken from each
rabbit at the time of peak lesion development and examined by
dark-field microscopy for the presence of motile treponemes. At the end
of the 90-day observation period, the animals were euthanized and the
second popliteal lymph node and testis were assayed for treponemes by
the infectivity test as described above (23). Rabbits in
which dark-field microscopy-positive lesions developed within the same
incubation period as the controls and which exhibited disseminated
infection by infectivity testing were considered susceptible to
reinfection. Rabbits were characterized as partially immune if they
exhibited dark-field microscopy-negative lesions without disseminated
infection or completely immune if lesions and disseminated infection
did not develop.
Sera.
Serum from infected, treated, and challenged test
rabbits, described above, was obtained 17 days postchallenge when
lesions appeared in the control animals at all inoculated sites (11 to 17 days). NRS was obtained from animals with negative venereal disease
research laboratory and T. pallidum immobilization tests (25, 26). Immune rabbit serum (IRS) from animals immune to challenge infection with 103 treponemes at four sites was
obtained from animals infected for 6 months following their
intratesticular injection with a total of 4 × 107
cells of T. pallidum.
Washed-killing treponemicidal assay.
Complement-dependent
treponemicidal antibody in sera from two representative rabbits each
from groups A, B, and C was measured quantitatively by using the
washed-killing assay as described previously (15). The
treponemicidal endpoint (TE) was defined as the reciprocal of the
highest dilution that exhibited
50% treponemal immobilization.
Treponemes immobilized under similar conditions have been shown to be
killed based upon virulence testing by intradermal injection of rabbits
(5). Undiluted sera exhibiting differences in motility of 21 to 49% between the test (with complement) and control (without
complement) tubes were considered to have a TE of
1. Control criteria
included a quantitative IRS with a previously established endpoint.
Assays were considered valid when the IRS titers were within 1 dilution
of the established endpoint and when residual complement activity could
be demonstrated as previously described (41). Each serum was
run in duplicate on different days, and tests were considered valid
when the endpoints were within 1 dilution of each other. The TE was
recorded as the reciprocal of the average of two valid assays.
Freeze-fracture electron microscopy.
Sera from the
representative rabbits that were tested for treponemicidal antibody
were further analyzed for their ability to aggregate TROMPs following
incubation with live T. pallidum cells. Each test serum was
set up in quadruplicate as follows. One hundred microliters of a
suspension containing approximately 5 × 107
treponemes/ml extracted in heat-inactivated (56°C for 30 min) NRS was
combined with 900 µl of heat-inactivated test serum (1:9 ratio of
treponemal suspension to test serum as used above for the
washed-killing assay). The serum-treponeme mixtures were equilibrated in an atmosphere of 95% N2 and 5% CO2 and
incubated at 34°C for 16 h to allow antibody against treponemal
surface molecules to bind in the absence of complement (100% of
treponemes were observed by dark-field microscopy to be actively motile
following the incubation). The suspensions were then centrifuged at
8,000 × g for 10 min to pellet the treponemes, and the
treponemal pellets were washed by suspension in 1 ml of
phosphate-buffered saline and then centrifuged as described above. Each
of the four treponemal pellets from an individual test serum was then
fixed for 1 h at room temperature by suspension in 500 µl of 0.1 M sodium cacodylate buffer (pH 7.4) containing 2.5% glutaraldehyde.
After fixation, the suspensions were centrifuged at 10,000 × g to pellet the treponemes, and the treponemal pellets were
then combined by suspension in 20 µl of 0.1 M sodium cacodylate
buffer (pH 7.4) containing 20% glycerol. Freeze-fracture electron
microscopy was then performed as previously described (9,
39). Particle enumeration was made by counting the total number
of individual and aggregated particles from 20 to 24 concave outer
membrane fracture faces (a total of approximately 1 µm2)
in sera from each immune-status group, NRS, and IRS. Particle aggregation was defined as two or more adjacent particles. Numbers of
particles within an aggregate were determined by both counting the
particles and determining the surface area of the aggregate in
comparison to the surface area of an individual particle. Standard error comparison was used for all particle enumeration and percent particle aggregation analyses. Significances were based upon Student's t test.
Status of immunity correlates with antibody that kills T. pallidum.
In order to determine the complement-dependent
treponemicidal-antibody level at a time of symptomatic infection
following challenge, sera from infected, penicillin-treated, and
challenged animals were obtained during the time of lesion appearance
in the control animals (17 days). As shown in Table
1, animals remaining susceptible to both
symptomatic and disseminated challenge reinfection, as determined from
the presence of typical, dark-field microscopy-positive lesions, showed
only low-titered (
1:1) serum treponemicidal activity. Similarly, no
treponemicidal activity was present in the serum of normal control
animals which showed identical lesions. In comparison, animals which
exhibited partial immunity, characterized by atypical dark-field
microscopy-negative lesions and the absence of disseminated reinfection
following challenge, showed a corresponding increase in the titer
(1:16) of treponemicidal activity. Finally, sera from animals
completely immune to both local (no lesion appearance) and disseminated
challenge reinfection had high-titered (1:128) treponemicidal activity,
as did sera from immune control animals (1:128).
Status of immunity correlates with antibody that aggregates
TROMPs.
In order to correlate immune status with antibody directed
against TROMPs, freeze-fracture electron microscopy was used to view
antibody-mediated TROMP aggregation following the incubation of test
and control sera with live T. pallidum cells. As shown in
Table 1 and Fig. 1, sera from animals
susceptible to challenge reinfection and having low-titered (
1:1)
treponemicidal activity as described above showed only a low level of
total particle aggregation (16.5% ± 5.6%) similar to the NRS
controls (13.4% ± 4.2%). As further shown in Fig.
2, the number of particles within these aggregates never exceeded three particles, again similar to those in
the normal serum controls. While sera from animals which exhibited partial immunity showed a corresponding increase in treponemicidal activity as described above (titer of 1:16), no significant increase in
total particle aggregation (18.9% ± 6.5%), compared to the susceptible group (16.5% ± 5.6%), was observed (Table 1). However, sera from the partially immune group did show a significant increase in
the number of particles within aggregates (P < 0.01),
which was found to be four to five particles in approximately 15% of the aggregates observed (Fig. 1 and 2). Finally, sera from animals completely immune to challenge reinfection and having
high-titered (1:128) treponemicidal activity as described above
showed significant aggregation of the total number of particles
observed (88.6% ± 5.4%; P < 0.0001) (Table 1 and
Fig. 1). In addition, approximately 50% of these aggregates contained
as many as four to six particles (Fig. 2). A similar, significantly
high level of particle aggregation (53.9% ± 7.8%; P < 0.0001) and numbers of particles within aggregates (approximately
20% containing four to six particles) was observed with sera from the
immune control rabbits (Table 1 and Fig. 2).

View larger version (137K):
[in this window]
[in a new window]
|
FIG. 1.
Freeze-fracture electron microscopy of T. pallidum following incubation in sera from infected and curatively
treated rabbits with various degrees of immunity to challenge
reinfection. T. pallidum was incubated for 16 h in the
absence of complement with serum from a rabbit susceptible to challenge
reinfection (A), a rabbit showing partial protection against challenge
reinfection (B), and a rabbit completely immune to challenge
reinfection (C). Arrows show nonaggregated (A and B) and aggregated (B
and C) TROMPs. Bar, 0.1 µm.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 2.
Determination of the number of particles in aggregates
following incubation of T. pallidum in sera from animals
with various degrees of immunity to challenge reinfection, in NRS, and
in IRS. The total number of particles from 20 to 24 concave outer
membrane fracture faces was determined. Numbers of particles within an
aggregate were determined by directly counting the particles and by
determining the surface area of an aggregate in comparison to the
surface area of an individual particle.
|
|